Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Apixaban”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04106700
What this trial is testing

Prophylaxis With Apixaban in Transplant Eligible Patients With Multiple Myeloma Receiving Induction Therapy With IMiDs

Who this might be right for
Venous Thromboembolism
Instituto de Investigacion Sanitaria La Fe 60
Early research (Phase 1)Study completedNCT02101112
What this trial is testing

Bioavailability of Apixaban Crushed Tablet

Who this might be right for
Thrombosis
Bristol-Myers Squibb 69
Not applicableUnknownNCT03100071
What this trial is testing

Central Venous Catheter (CVC) Associated Deep Vein Thrombosis (DVT) in Cancer Patients

Who this might be right for
Cancer PatientsCentral Venous Catheter ThrombosisUpper Extremity Thrombosis
Michael Kovacs 70
Not applicableStudy completedNCT03847181
What this trial is testing

Study to Learn More About the Benefits and Side-effects of Drugs Rivaroxaban and Apixaban Compared to the Drug Warfarin for Stroke Prevention in Patients With Rapid and Irregular Heartbeat Which is Not Due to a Heart-valve Fault (Non-valvular Atrial Fibrillation) in the UK Routine Clinical Practice

Who this might be right for
Atrial Fibrillation
Bayer 45,164
Not applicableStudy completedNCT03112525
What this trial is testing

DAPHNE Study: Direct Anticoagulant PHarmacogeNEtic

Who this might be right for
Anticoagulants and Bleeding Disorders
University Hospital, Geneva 300
Not applicableStudy completedNCT02492828
What this trial is testing

Adherence of Apixaban and Warfarin in Patients With Arterial Fibrillation in Real-world Setting in Sweden

Who this might be right for
Anticoagulation
Bristol-Myers Squibb 41,000
Post-approval studies (Phase 4)UnknownNCT04344717
What this trial is testing

Pharmacokinetics of Apixaban in Patients With Short Bowel Syndrome Requiring Long Term Parenteral Nutrition

Who this might be right for
Short Bowel SyndromeAnticoagulation
Universitaire Ziekenhuizen KU Leuven 84
Not applicableUnknownNCT06171984
What this trial is testing

Thrombophilia Assessment Under DOAC: Effectiveness of Activated Charcoal

Who this might be right for
Thrombophilia
University Hospital, Strasbourg, France 200
Large-scale testing (Phase 3)Looking for participantsNCT07005024
What this trial is testing

DOAC - Dosing Options in AntiCoagulation Prophylaxis

Who this might be right for
CancerVTE (Venous Thromboembolism)
University of Vermont 996
Testing effectiveness (Phase 2)Ended earlyNCT00852397
What this trial is testing

Evaluate the Safety of Apixaban in Acute Coronary Syndrome (ACS) Japanese Patients

Who this might be right for
Acute Coronary Syndrome
Pfizer 151
Early research (Phase 1)UnknownNCT05491460
What this trial is testing

Pharmacokinetics and Point of Care Testing of Direct Oral Anticoagulants Subjects

Who this might be right for
Anticoagulant Therapy
Doasense GmbH 24
Post-approval studies (Phase 4)UnknownNCT06184113
What this trial is testing

Apixaban for the Prevention of Latent Biological Valve Thrombosis

Who this might be right for
Aortic Valve ReplacementAntithrombotic TherapyBioprosthetic Valve Thrombosis+1 more
Clinical Hospital Centre Zagreb 166
Not applicableLooking for participantsNCT07461532
What this trial is testing

Efficacy of Apixaban in Treating Portal Vein Thrombosis Occurring More Than One Year After LSD

Who this might be right for
CirrhosisSplenectomyPortal Vein Thrombosis+1 more
Northern Jiangsu People's Hospital 20
Post-approval studies (Phase 4)Study completedNCT02608099
What this trial is testing

Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Baim Institute for Clinical Research 300
Not applicableStudy completedNCT01885598
What this trial is testing

Eliquis Regulatory Post Marketing Surveillance

Who this might be right for
NonValvular Atrial Fibrillation
Bristol-Myers Squibb 3,335
Not applicableStudy completedNCT02228798
What this trial is testing

Perioperative Anticoagulant Use for Surgery Evaluation Study

Who this might be right for
Atrial Fibrillation
McMaster University 3,135
Post-approval studies (Phase 4)Study completedNCT02559856
What this trial is testing

Comparison of Bleeding Risk Between Rivaroxaban and Apixaban: The Pilot Study

Who this might be right for
Venous Thromboembolism
Ottawa Hospital Research Institute 71
Testing effectiveness (Phase 2)Study completedNCT03288454
What this trial is testing

Phase 2 Study of Apixaban Reversal by Ciraparantag as Measured by WBCT

Who this might be right for
Healthy
Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc. 60
Testing effectiveness (Phase 2)Study completedNCT04218266
What this trial is testing

Study to Gather Information About the Proper Dosing of the Oral FXIa Inhibitor BAY 2433334 and to Compare the Safety of the Study Drug to Apixaban, a Non-vitamin K Oral Anticoagulant (NOAC) in Patients With Irregular Heartbeat (Atrial Fibrillation) That Can Lead to Heart-related Complications.

Who this might be right for
Atrial Fibrillation (AF)
Bayer 755
Not applicableStudy completedNCT03026556
What this trial is testing

The Comparative Safety and Effectiveness of Dabigatran, Versus Rivaroxaban, and Apixaban Utilized in the Department of Defense Non-Valvular Atrial Fibrillation Patient Population: A Retrospective Database Analysis

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 42,534
Next Page